Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Jan 2026 and Mar 2026.
- Largest single sale: $2.6M (4,723 shares) of Madrigal Pharmaceuticals, Inc. on Dec 10, 2025. Filing
- Last sale before this period: Aug 12, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. (MDGL) | Director | Jul 26, 2016 | Jun 18, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 17, 2026, Madrigal Pharmaceuticals, Inc.: 454 shares granted. 1 filing: 1
- Mar 6, 2026, Madrigal Pharmaceuticals, Inc.: sold 491 shares for $212K, to cover taxes. 1 filing: 1
- Jan 26, 2026, Madrigal Pharmaceuticals, Inc.: sold 647 shares for $319K, to cover taxes. 1 filing: 1
- Jan 20, 2026, Madrigal Pharmaceuticals, Inc.: sold 2,238 shares for $1.1M, to cover taxes. 1 filing: 1
- Jan 9, 2026, Madrigal Pharmaceuticals, Inc.: sold 18,650 shares for $9.7M, under a disclosed plan; 18,650 shares acquired by exercising options. 2 filings: 1, 2
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.